By Emeritus Professor Andrew Lloyd

Journal articles

Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A, 2006, 'Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load', J Infect Dis, 193, pp. 664 - 671, http://dx.doi.org/10.1086/500248

Elliott LN; Lloyd AR; Ziegler JB; Ffrench RA, 2006, 'Protective immunity against hepatitis C virus infection', Immunology and Cell Biology, 84, pp. 239 - 249

Wallace C; Hailstone S; Lloyd A, 2005, 'Bug Breakfast in the Bulletin: Blood-borne viruses in correctional facilities.', New South Wales public health bulletin, 16, pp. 166 - 167

Smith A; Vollmer-Conna US; Geczy A; Dunckley H; Bennett BK; Hickie IB; Lloyd AR, 2005, 'Does genotype mask the relationship between psychological factors and immune function?', Brain Behavior and Immunity, 19, pp. 147 - 152

Helbig K; Ayres J; Dunckley H; Lloyd AR; Robson J; Marmion BP; Harris R, 2005, 'Immune response genes in the post-Q-fever fatigue syndrome, Q fever endocarditis and uncomplicated acute primary Q fever', QJM - an International Journal of Medicine, 98, pp. 565 - 574

Elliott LN; Ziegler JB; Palasanthiran P; Giles ME; Lloyd AR; Ffrench R, 2005, 'Infrequent detection of HCV-specific cellular immune responses in infants born to HCV-positive mothers', Tissue Antigens, 66, pp. 405 - 406

Freeman AJ; Marinos G; Ffrench R; Lloyd AR, 2005, 'Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyteactivity is associated with a response to combination IFN-alpha andribavirin treatment among patients with chronic hepatitis C virusinfection', Journal of Viral Hepatitis, 12, pp. 125 - 129

Harvey CE; Lloyd AR; Post JJ, 2005, 'Loss of CCR5+ T cells in the liver of HCV infected individuals co-infected with HIV', Tissue Antigens, 66, pp. 437 - 438

Flynn J; Goy K; Woollard D; Lloyd AR; Ffrench R, 2005, 'Multi-specific IFN-gamma and IL-2 T cell responses in chronic HCV infection', Tissue Antigens, 66, pp. 419 - 419

Jagger E; Hettiaratchi A; Carol H; Cameron BA; Vollmer-Conna US; Davenport T; Hickie IB; Wakefield D; Lloyd AR, 2005, 'Polymorphisms in the interleukin-10 gene are associated with duration of illness following primary Epstein-Barr virus infection', Tissue Antigens, 66, pp. 452 - 453

Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm M, 2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, 139, pp. 411 - 420

Scroop GC; Burnet RB, 2004, 'To exercise or not to exercise in chronic fatigue syndrome?', MEDICAL JOURNAL OF AUSTRALIA, 181, pp. 578 - 579, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06457.x

Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; Mcphee D; Mclachlan AJ; Gelder F; Lewin S; Liauw WS; Williams KM, 2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, 5, pp. 91 - 98

Connor SJ; Paraskevopoulos N; Newman R; Cuan N; Hampartzoumian T; Lloyd AR; Grimm M, 2004, 'CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, 53, pp. 1287 - 1294

Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber P; Marinos G; Levy MH; Kaldor JM; Dolan K; Ffrench R; Lloyd AR; Rawlinson WD, 2004, 'Clearance of Hepatitis C Viremia Associated with Cellular Immunity in the Absence of Seroconversion in the Hepatitis C Incidence and Transmission in Prisons Study Cohort', Journal of Infectious Diseases, 189, pp. 1846 - 1855

Bennett BK; Goldstein D; Lloyd AR; Davenport T; Hickie IB, 2004, 'Fatigue and psychological distress - exploring the relationship in women treated for breast cancer', European Journal of Cancer, 40, pp. 1689 - 1695

Freeman A; Ffrench R; Post JJ; Harvey CE; Gilmour S; White PA; Marinos G; Van Beek IA; Rawlinson WD; Lloyd AR, 2004, 'Prevalence of Production of Virus-Specific Interferon- among Seronegative Hepatitis C-Resistant Subjects Reporting Injection Drug Use', Journal of Infectious Diseases, 190, pp. 1093 - 1097

Vollmer-Conna U; Fazou C; Cameron B; Li H; Brennan C; Luck L; Davenport T; Wakefield D; Hickie I; Lloyd A, 2004, 'Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans', Psychol Med, 34, pp. 1289 - 1297

Stafford JA; Post JJ; Kaldor JM; Pan Y; Haber P; Lloyd AR; Dolan K, 2004, 'Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, Australia', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 81, pp. 448 - 452, http://dx.doi.org/10.1093/jurban/jth129

Smith A; Vollmer-Conna US; Bennett BK; Wakefield D; Hickie IB; Lloyd AR, 2004, 'The relationship between distress and the development of a primary immune response to a novel antigen', Brain Behavior and Immunity, 18, pp. 65 - 75

Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome?', Medical Journal of Australia, 181, pp. 578 - 580, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06459.x

Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome? No longer a question', Medical Journal of Australia, 180, pp. 437 - 438

Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome? Reply', Medical Journal of Australia, 181, pp. 579 - 580

Freeman AJ; Ffrench RA; Post JJ; Harvey CE; Gilmour S; White PA; Marinos G; Rawlinson WD; Van Beek IA; Lloyd AR, 2004, 'Virus-specific cellular immunity is prevalent among hepatitis C-resistant injecting drug users', Journal of Infectious Diseases, 190, pp. 1093 - 1097

Grimm MC; Newman R; Hassim Z; Cuan N; Connor SJ; Le Y; Wang JM; Oppenheim JJ; Lloyd AR, 2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, 171, pp. 4990 - 4994, http://dx.doi.org/10.4049/jimmunol.171.10.4990

Vollmer-Conna U; Davenport T; Hickie I; Wakefield D; Lloyd A, 2003, 'Sick, sleepy and sad', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 95 - 95, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200420&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith AJ; Vollmer-Conna U; Bennett B; Wakefield D; Hickie IB; Lloyd AR, 2003, 'The effect of examination stress on the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith AJ; Bennett B; Vollmer-Conna U; Wakefield D; Hickie IB; Lloyd AR, 2003, 'The relationship between distress and the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200402&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harvey CE; Post JJ; Palladinetti P; Freeman AJ; Ffrench R; Kumar RK; Marinos G; Lloyd AR, 2003, 'Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation', Journal of Leukocyte Biology, 74, pp. 360 - 369

Reeves W; Lloyd AR; Vernon S; Klimas N; Jason L; Bleijenberg G; Evengard B; White P; Nisenbaum R; Unger E, 2003, 'Identification of ambiguities in the 1994 chronic fatigue syndromeresearch case definition and recommendations for resolution', BMC Health Services Research, 3, pp. 1 - 9, http://dx.doi.org/10.1186/1472-6963-3-1

Robertson PW; Beynon S; Whybin R; Brennan CM; Vollmer-Conna US; Hickie IB; Lloyd AR, 2003, 'Measurement of EBV-1gG and t-VCA avidity aids the early and reliable diagnosis of primary EBV infection', Journal of Medical Virology, 70, pp. 617 - 623

Senanayake SN; Kelly JJ; Lloyd AR; Waliuzzaman Z; Goldstein D; Rawlinson WD, 2003, 'Multicentric Castleman's Disease Treated with Antivirals and Immunosuppressants', Journal of Medical Virology, 71, pp. 399 - 403

Xue ML; Wakefield D; Willcox MD; Lloyd AR; Di Girolamo N; Cole NA; Thakur A, 2003, 'Regulation of MMPs and TIMPs by IL-1â during Corneal Ulceration and Infection', Investigative Ophthalmology and Visual Science, 44, pp. 2020 - 2025

Xue ML; Thakur A; Willcox MD; Zhu H; Lloyd AR; Wakefield D, 2003, 'Role and regulation of CXC-chemokines in acute experimental keratitis', Experimental Eye Research, 76, pp. 221 - 231

Freeman A; Pan Y; Harvey CE; Post JJ; Law MG; White PA; Rawlinson WD; Lloyd AR; Marinos G; Ffrench R, 2003, 'The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection', Journal of Hepatology, 38, pp. 349 - 356

Grimm M; Newman R; Hassim Z; Cuan N; Connor SJ; Wang J; Oppenheim JJ; Lloyd AR, 2003, 'Vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors', Journal of Immunology, 171, pp. 4990 - 4994

Dore GJ; Freeman AJ; Kaldor JM; Post JJ; Harvey CE; Ffrench RA; Lloyd AR; Mehta SH; Cox AL; Strathdee SA; Vlahov D; Thomas DL, 2002, 'Immunity against hepatitis C virus infection [2] (multiple letters)', Lancet, 360, pp. 1019 - 1020, http://dx.doi.org/10.1016/s0140-6736(02)11102-0

Loblay R; Toulkidis V; Hickie I; Lloyd A; Phillips B; Phoon WO; Rowe K; Steven I; Wakefield D; Watson D; Stewart G; Bertouch J; Cistulli P; Darveniza P; Ellis C; Gatenby P; Gillis D; Hickie I; Lloyd A; Phillips B; Phoon WO; Rowe K; Steven I; Wakefield D; Watson DO; Toulkidis V, 2002, 'Clinical practice guidelines - 2002', MEDICAL JOURNAL OF AUSTRALIA, 176, pp. S21 - S55

Dore GJ; Freeman A; Kaldor JM, 2002, '. Immunity against hepatitis C virus infection', Lancet, 360, pp. 1019 - 1020

Post JJ; Konecny P; Lloyd AR; Jones PD, 2002, 'Acute Q fever and brachial neuritis: Case report and literature review', Infection, 30, pp. 400 - 402

Bertouch J; Cistulli P; Darveniza P; Ellis C; Gatenby P; Gillis D; Hickie IB; Phillips I; Phoon W; Rowe K; Steven I; Wakefield D; Watson D, 2002, 'Chronic Fatigue Syndrome Clinical Practice Guidelines', Medical Journal of Australia, 176

Kumar RK; Thomas PS; Seetoo DQ; Herbert C; McKenzie AN; Foster PS; Lloyd AR, 2002, 'Eotaxin expression by epithelial cells and plasma cells in chronic asthma', Lab Invest, 82, pp. 495 - 504, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11950906

Post JJ; Freeman A; Harvey CE; Ffrench R; Lloyd AROLA, 2002, 'Immunity against hepatitis C virus infection', Lancet, 360, pp. 1020 - 1020

White PA; Freeman A; Marinos G; Ffrench R; Rawlinson WD; Pan Y; Lloyd AR, 2002, 'Quantification of Hepatitis C Virus in Human Liver and Serum Samples by Using LightCycler Reverse Transcriptase PCR', Journal of Clinical Microbiology, 40, pp. 4346 - 4348, http://dx.doi.org/10.1128/JCM.40.11.4346-4348.2002

Thakur A; Xue ML; Stapleton FJ; Lloyd AR; Wakefield D; Willcox MD, 2002, 'The balance of pro- and anti-inflammatory cytokines correlates with the outcome of acute experimental Pseudomonas keratitis', Infection and Immunity, 70, pp. 2187 - 2197

Smith AJ; Bennett B; Vollmer-Conna U; Wakefield D; Hickie IB; Lloyd AR, 2001, 'The effect of distress on the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 53, pp. 175 - 175, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202876001305&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hickie IB; Bansal AS; Kirk KM; Lloyd AR; Martin NG, 2001, 'A twin study of the etiology of prolonged fatigue and immune activation', Twin Research, pp. 94 - 102

Post JJ; Dolan K; Whybin R; Carter I; Haber P; Lloyd AR, 2001, 'Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route', Medical Journal of Australia, 174, pp. 183 - 184

Connor SJ; Cardillo R; Cuan N; Amansec S; Conway P; Lloyd AR; Grimm MC, 2001, 'Amelioration of TNBS colitis in mice using preblotics', Gastroenterology, 120, pp. A82 - A82, http://dx.doi.org/10.1016/s0016-5085(08)80404-0

Freeman A; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM, 2001, 'Estimating progression to cirrhosis in chronic hepatitis C virus infection.', Hepatology, pp. 809 - 816

Back to profile page